JUPITER, Fla., April 16, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a ...

Dyadic International will present on its C1 platform at the 2025 World Vaccine Congress, focusing on avian influenza and preclinical research. Dyadic International, Inc., a biotechnology company ...

Please contact [email protected], if you would like to schedule a meeting with Dyadic management. About Dyadic International, Inc. Dyadic International, Inc., is a biotechnology company focused ...

Dyadic International, Inc. (NASDAQ:DYAI) Q4 2024 Earnings Call Transcript March 26, 2025 Dyadic International, Inc. misses on earnings expectations. Reported EPS is $-0.05 EPS, expectations were ...

Mark Emalfarb, Dyadic’s CEO, said, “We are grateful for CEPI’s funding and the support of Fondazione Biotecnopolo di Siena, led by Dr. Rino Rappuoli, in advancing Dyadic’s C1 platform for ...

March 26, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (DYAI), a biotechnology company focused on the efficient large-scale manufacture of proteins for use in human and animal vaccines and ...

You'll need to find the Sunless Cell fragments in Destiny 2 if you want to complete the Dyadic Perfection quest and earn the final intrinsic upgrade for the Barrow ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Good evening and welcome to Dyadic International's Year-End 2024 Conference Call. Currently, all participants are in a listen-only mode. Following management's prepared remarks, there will be a ...